J&J’s DePuy Synthes acquires spine implant maker Expanding Innovations

Johnson & Johnson’s DePuy Synthes has acquired Expanding Innovations, a spine implant maker. This acquisition adds expandable interbody cage technology to DePuy Synthes' portfolio, strengthening its position in the growing expandable cage segment. The non-screw-based design aims to reduce post-operative complications and will integrate with the TriALTIS Spine System and VELYS enabling tech.

Johnson & Johnson’s DePuy Synthes acquired Expanding Innovations, adding expandable interbody cage technology for spine surgery. * The deal strengthens DePuy Synthes’ Spine portfolio, expanding its presence in the fast-growing expandable cage segment. * Expanding Innovations’ non-screw-based cage design targets lower post-operative cage collapse and vertebral body subsidence. * The acquired technology will complement the TriALTIS Spine System, integrating into the VELYS enabling tech portfolio for Spine. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via Business Wire (Ref. ID: 20260716718603) on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Johnson & Johnson’s DePuy Synthes acquired Expanding Innovations, adding expandable interbody cage technology for spine surgery. * The deal strengthens DePuy Synthes’ Spine portfolio, expanding its presence in the fast-growing expandable cage segment. * Expanding Innovations’ non-screw-based cage design targets lower post-operative cage collapse and vertebral body subsidence. * The acquired technology will complement the TriALTIS Spine System, integrating into the VELYS enabling tech portfolio for Spine. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Johnson & Johnson published the original content used to generate this news brief via Business Wire (Ref. ID: 20260716718603) on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)